Life Sciences Push Agilent Q2 Revenues up 32 Percent

In Life Sciences, pharma and biotech revenues increased 16 percent year over year on an organic basis, while academic and government revenues grew 9 percent.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories